1. Fleming A. On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to their Use in the Isolation of B. influenzæ. Br J Exp Pathol, 1929 ;10(3):226–36.
2. Wenzler E, Maximos M, Asempa TE, Biehle L, Schuetz AN, Hirsch EB. Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights
from the Society of Infectious Diseases Pharmacists. Pharmacotherapy, 2023;43(4):264-278.
3. Gajic I, Kabic J, Kekic D, et al. Antimicrobial Susceptibility Testing: A Comprehensive Review of Currently Used Methods. Antibiotics (Basel), 2022;11(4):427.
4. Salam MA, Al-Amin MY, Pawar JS, Akhter N, Lucy IB. Conventional methods and future trends in antimicrobial susceptibility testing. Saudi J Biol Sci, 2023;30(3):103582.
5. L. Barth Reller, Melvin Weinstein, James H. Jorgensen, Mary Jane Ferraro. Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices, Clinical Infectious
Diseases,2009, 49(11):1749–1755.
6. Turnidge, JD, Jorgensen JH, Zimmer BA (2023) Susceptibility Test Methods: General Considerations. Manual of Clinical Microbiology. 13th Edition, American Society of Microbiology.
7. Khan ZA, Siddiqui MF, Park S. Current and Emerging Methods of Antibiotic Susceptibility Testing. Diagnostics (Basel), 2019;9(2):49.
8. https://www.eucast.org/newsiandr.
9. Kahlmeter G, Turnidge J. How to: ECOFFs-the why, the how, and the don’ts of EUCAST epidemiological cutoff values. Clin Microbiol Infect, 2022, 28(7):952-954.
10. Mouton JW, Brown DF, Apfalter P, et al. The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. Clin Microbiol Infect, 2012;18(3): E37-
45.
11. Paul G. Ambrose, Sujata M. Bhavnani, Christopher M. Rubino, et al. Pharmacokinetics-Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore, Clinical Infectious
Diseases, 2007; 44(1):79–86.
12. Kowalska-Krochmal B, Dudek-Wicher R. The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance. Pathogens, 2021;10(2):165
13. EUCAST Disk Diffusion Method for Antimicrobial Susceptibility Testing Version 12.0 (January 2024) https://www.eucast.org/ast_of_bacteria/disk_diffusion_methodology
14. Koeth LM, Miller LA. (2023) Antimicrobial Susceptibility Test Methods: Dilution and Disk Diffusion Methods Manual of Clinical Microbiology. 13th Edition, American Society of Microbi-
ology.
15. Clinical and Laboratory Standards Institute. M02: Performance Standards for Antimicrobial Disk Susceptibility Tests. 14th ed. Clinical and Laboratory Standards Institute; Wayne, PA, USA:
2024.
16. Le Page S, Dubourg G, Rolain JM. Evaluation of the Scan 1200 as a rapid tool for reading antibiotic susceptibility testing by the disc diffusion technique. J. Antimicrob. Chemother, 2016;
71:3424–3431.
17. Idelevich EA, Becker K, Schmitz J, Knaack D, Peters G, Köck R. Evaluation of an Automated System for Reading and Interpreting Disk Diffusion Antimicrobial Susceptibility Testing of Fas-
tidious Bacteria. PLoS One. 2016;11(7): e0159183
18. Van den Bijllaardt W, Buiting AG, Mouton JW, Muller AE. Shortening the incubation time for antimicrobial susceptibility testing by disk diffusion for Enterobacteriaceae: How short can it be
and are the results accurate? Int. J. Antimicrob. Agents. 2017; 49:631–637.
19. Hombach M, Jetter M, Blöchliger N, Kolesnik-Goldmann N, Böttger EC. Fully automated disc diffusion for rapid antibiotic susceptibility test results: A proof-of-principle study. J. Antimicrob.
Chemother, 2017; 72:1659–1668.
20. EUCAST. EUCAST rapid antimicrobial susceptibility testing (RAST) directly from positive blood culture bottles. Version 4.0, April 2023. https://www.eucast.org/rapid-ast-in-bloodcultures/
methods.
21. Jonasson E, Matuschek E, Kahlmeter G. The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles. J Antimicrob Chemother,
2020;75(4):968-978.
22. Åkerlund A, Jonasson E, Matuschek E, Serrander L, Sundqvist M, Kahlmeter G; RAST Study Group. EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation
in 55 European laboratories. J Antimicrob Chemother, 2020;75(11):3230-3238.
23. Jonasson E, Matuschek E, Kahlmeter G. Evaluation of prolonged incubation time of 16-20 h with the EUCAST rapid antimicrobial susceptibility disc diffusion testing method. J Antimicrob
Chemother, 2023;78(12):2926-2932.
24. Clinical and Laboratory Standards Institute. M07: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. 12th ed. Clinical and Laboratory Standards
Institute; Wayne, PA, USA: 2024.
25. EUCAST https://www.eucast.org/ast_of_bacteria/mic_determination
26. Karlowsky JA, Richter SS, Patel JB. (2023) Antimicrobial Susceptibility Testing Systems. Manual of Clinical Microbiology. 13th Edition, American Society of Microbiology.
27. Zhou, M, Wang Y, Liu C, et al. Comparison of five commonly used automated susceptibility testing methods for accuracy in the China Antimicrobial Resistance Surveillance System (CARSS)
hospitals. Infect. Drug Resist, 2018; 11:1347–1358.
28. Bulik CC, Fauntleroy KA, Jenkins SG, et al. Comparison of meropenem MICs and susceptibilities for carbapenemase-producing Klebsiella pneumoniae isolates by various testing methods. J.
Clin. Microbiol, 2010; 48:2402.
29. Woodford N, Eastaway AT, Ford M, et al. Comparison of BD Phoenix, Vitek 2, and MicroScan Automated Systems for detection and inference of mechanisms responsible for carbapenem
resistance in Enterobacteriaceae. J. Clin. Microbiol, 2010; 48:2999.
30. Buchan, BW, Anderson NW, Ledeboer NA. Comparison of BD Phoenix and bioMérieux Vitek 2 automated systems for the detection of macrolide-lincosamide-streptogramin B resistance
among clinical isolates of Staphylococcus. Diagn. Microbiol. Infect. Dis, 2012; 72: 291–294.
31. Richter SS, Howard WJ, Weinstein MP, et al. Multicenter evaluation of the BD Phoenix Automated Microbiology System for antimicrobial susceptibility testing of Streptococcus species. J.
Clin. Microbiol, 2007; 45: 2863.
32. Khan A, Arias CA, Abbott A, Dien Bard J, Bhatti MM, Humphries RM. Evaluation of the Vitek 2, Phoenix, and MicroScan for antimicrobial susceptibility testing of Stenotrophomonas mal-
tophilia. J. Clin. Microbiol, 2021; 59: e0065421.
33. Evangelista AT, Karlowsky J.A. Manual of Commercial Methods in Clinical Microbiology. John Wiley & Sons, Inc.; Hoboken, NJ, USA: 2016. Automated and Manual Systems for Antimicro-
bial Susceptibility Testing of Bacteria; pp. 414–432.
34. Benkova M, Soukup O, Marek J. Antimicrobial susceptibility testing: Currently used methods and devices and the near future in clinical practice. J. Appl. Microbiol, 2020; 129:806–822.
35. Marschal M, Bachmaier J, Autenrieth I, Oberhettinger P, Willmann M, Peter S. Evaluation of the Accelerate Pheno system for fast identification and antimicrobial susceptibility testing from
positive blood cultures in bloodstream infections caused by Gram-negative pathogens. J Clin Microbiol, 2017;55:2116–2126
36. Gallois E, Fihman V, Danjean M, et al. QMAC-dRAST for the direct testing of antibiotic susceptibility for Enterobacterales in positive blood-culture broth: a comparison of the performances
with the MicroScan system and direct disc diffusion testing methods. J Antimicrob Chemother, 2023;78(3):684-691.
37. Anton-Vazquez V, Adjepong S, Suarez C, Planche T. Evaluation of a new Rapid Antimicrobial Susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and
accuracy of Alfred 60AST. BMC Microbiol, 2019, 29;19(1):268.
38. Tibbetts R, George S, Burwell R, et al. Performance of the Reveal Rapid Antibiotic Susceptibility Testing System on Gram-Negative Blood Cultures at a Large Urban Hospital. J Clin Microbiol,
2022;60(6): e0009822.
39. Esse J, Träger J, Valenza G, Bogdan C, Held J. Rapid phenotypic antimicrobial susceptibility testing of Gram-negative rods directly from positive blood cultures using the novel Q-linea ASTar
system. J Clin Microbiol, 2023;61(11): e0054923.
40. Silva-Dias A, Pérez-Viso B, Martins-Oliveira I, et al. Evaluation of FASTinov Ultrarapid Flow Cytometry Antimicrobial Susceptibility Testing Directly from Positive Blood Cultures. J Clin
Microbiol, 2021;59(10): e0054421.
41. Bolmström A, Arvidson S, Ericsson M, Karlson ⁺. Program and abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American
Society for Microbiology; 1988. A novel technique for direct quantification of antimicrobial susceptibility of microorganisms, abstr. 1209; p. 325.
42. Shields RK, Clancy CJ, Pasculle AW, et al. Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteria-
ceae and Pseudomonas aeruginosa. J. Clin. Microbiol, 2018;56: e01093-17.
43. Humphries RM, Hindler JA, Magnano P, Wong-Beringer A, Tibbetts R, Miller SA. Performance of ceftolozane-tazobactam etest, MIC test strips, and disk diffusion compared to reference
broth microdilution for-Lactam-Resistant Pseudomonas aeruginosa isolates. J. Clin. Microbiol, 2018;56: e01633-17.
44. Gajic I, Ranin L, Kekic D, et al. Tigecycline susceptibility of multidrug-resistant Acinetobacter baumannii from intensive care units in the western Balkans. Acta Microbiol Immunol Hung, 2020;
67:176–181.
45. Satlina MJ. The search for a practical method for colistin susceptibility testing: Have we found it by going back to the future? J. Clin. Microbiol, 2018;57: e01608-18.
46. Pereckaite L, Tatarunas V, Giedraitiene A. Current antimicrobial susceptibility testing for beta-lactamase-producing Enterobacteriaceae in clinical settings. J. Microbiol Methods, 2018;152:154–
164.
47. Martinez-Martinez L, Cantón Spain R, Stefani S, et al. EUCAST Guidelines for Detection of Resistance Mechanisms and Specific Resistances of Clinical and/or Epidemiological Importance.[(accessed on 27 February 2022)]. Available online: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance_mechanisms/EUCAST_detection_of_resistance_mecha-
nisms_170711.pdf
48. Peter-Getzlaff S, Polsfuss S, Poledica M, et al. Detection of AmpC beta-lactamase in Escherichia coli: Comparison of three phenotypic confirmation assays and genetic analysis. J. Clin Micro-
biol, 2011; 49:2924–2932.
49. Yusof A, Engelhardt A, Karlsson A, et al. Evaluation of a new etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, hete-
rogeneous GISA. J. Clin Microbiol, 2008; 46:3042–3047.
50. Laishram S, Pragasam AK, Bakthavatchalam YD, Veeraraghavan B. An update on technical, interpretative and clinical relevance of antimicrobial synergy testing methodologies. Indian J Med
Microbiol, 2017;35(4):445-468.
51. Simner PJ, Humphries RM. (2023) Special Phenotypic Methods for Detecting Antibacterial Resistance. Manual of Clinical Microbiology. 13th Edition, American Society of Microbiology.
52. Merlino J, Leroi M, Bradbury R, Veal D, Harbour C. New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S. aureus. J. Clin Microbiol, 2000, 38,
2378–2380.
53. Ledeboer, NA, Das K, Eveland M, et al. Evaluation of a novel chromogenic agar medium for isolation and differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus
faecalis isolates. J. Clin Microbiol, 2007; 45, 1556–1560.
54. Glupczynski Y, Berhin C, Bauraing C, Bogaerts P. Evaluation of a New Selective Chromogenic Agar Medium for Detection of Extended-Spectrum-Lactamase-Producing Enterobacteriaceae.
J. Clin Microbiol, 2007, 45, 501–505.
55. Samra Z, Bahar J, Madar-Shapiro L, Aziz N, Israel S, Bishara J. Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae. J. Clin Microbiol, 2008; 46:
3110–3111.
56. Gordon NC, Wareham DW. Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients.
J. Clin Microbiol, 2009; 47:2249–2251.
57. Perry JD. A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics. Clin Microbiol Rev, 2017 ;30(2):449-479.
58. Glupczynski Y, Berhin C, Bauraing C, Bogaerts P. Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum beta-lactamase-producing Enterobacteriaceae. J
Clin Microbiol, 2007;45:501–505.
59. Samra Z, Bahar J, Madar-Shapiro L, Aziz N, Israel S, Bishara J. Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae. J Clin Microbiol, 2008;46:3110–
3111.
60. Gordon NC, Wareham DW. Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients. J
Clin Microbiol, 2009;47:2249–2251.
61. Higgins PG, Nowak J, Devigne L, Seifert H. Evaluation of chromID® CARBA and chromID® OXA-48 media for the detection of carbapenemase producing Acinetobacter spp. Abstr 24th Eur
Congr Clin Microbiol Infect Dis, abstr eP322, 2014.
62. Zarakolu P, Day KM, Lanyon CV, Cummings SP, Perry JD. An evaluation of chromID® CARBA for the isolation of carbapenem-resistant Acinetobacter baumannii. Abstr 25th Eur Congr Clin
Microbiol Infect Dis, abstr EVO528, 2015.
63. Celik C, Kalin G, Cetinkaya Z, Ildiz N, Ocsoy I. Recent Advances in Colorimetric Tests for the Detection of Infectious Diseases and Antimicrobial Resistance. Diagnostics (Basel),
2023;13(14):2427.
64. Nordmann P, Dortet L, Poirel L. Rapid detection of extended-spectrum-β-lactamase-producing 28 Enterobacteriaceae. J Clin Microbiol, 2012;50(9):3016-22.
65. Renvoise A, Decre D, Amarsy-Guerle R, Huang TD, Jost C, et al. Evaluation of the β-Lacta test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobac-
teriaceae. J Clin Microbiol, 2013;51(12):4012-7.
66. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis, 2012; 18:1503–1507.
67. Compain F, Gallah S, Eckert C, et al. Assessment of Carbapenem Resistance in Enterobacteriaceae with the Rapid and Easy-to-Use Chromogenic β Carba Test. J Clin Microbiol, 2016;54(12):3065-
3068.
68. Nordmann P, Jayol A, Poirel L. Rapid detection of polymyxin resistance in Enterobacteriaceae. Emerg Infect Dis, 2016;22(6):1038–1043.
69. Sadek M, Tinguely C, Poirel L, Nordmann P. Rapid Polymyxin/Pseudomonas NP test for rapid detection of polymyxin susceptibility/resistance in Pseudomonas aeruginosa. Eur J Clin Micro-
biol Infect Dis, 2020;39(9):1657-1662.
70. Bouvier M, Sadek M, Pomponio S, D’Emidio F, Poirel L, Nordmann P. RapidResa Polymyxin Acinetobacter NP® Test for Rapid Detection of Polymyxin Resistance in Acinetobacter baumannii.
Antibiotics (Basel), 2021;10(5):558.
71. Rodriguez CH, Maza J, Tamarin S, Nastro M, Vay C, Famiglietti A. In-house rapid colorimetric method for detection of colistin resistance in Enterobacterales: A significant impact on resis-
tance rates. J Chemother, 2019;31(7-8):432-435.
72. Gelmez GA, Can B, Hasdemir U, Soyletir G. Evaluation of two commercial methods for rapid detection of the carbapenemase-producing Klebsiella pneumoniae. J Microbiol Methods, 2020,
10;178:106084.
73. Florio W, Baldeschi L, Rizzato C, Tavanti A, Ghelardi E, Lupetti A. Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area. Front Cell Infect Microbiol,
2020; 10:572909.
74. Johansson A, Nagy E, Soki J. Instant screening and verification of carbapenemase activity in Bacteroides fragilis in positive blood culture, using matrix-assisted laser desorption ionization–
time of flight mass spectrometry. J. Med. Microbiol, 2014;63, 1105–1110.
75. Johansson A, Nagy E, Soki J, ESGAI (ESCMID Study Group on Anaerobic Infections). Detection of carbapenemase activities of Bacteroides fragilis strains with matrix-assisted laser desorption
ionization–time of flight mass spectrometry (MALDI-TOF MS). Anaerobe, 2014; 26:49–52.
76. Oviano M, Sparbier K, Barba MJ, Kostrzewa M, Bou G. Universal protocol for the rapid automated detection of carbapenem-resistant gram-negative bacilli directly from blood cultures by
matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF/MS). Int. J. Antimicrob. Agents, 2016; 48:655–660.
77. Gaibani P, Galea A, Fagioni M, Ambretti S, Sambri V, Landini MP. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of KPC-produ-
cing Klebsiella pneumoniae. J. Clin. Microbiol, 2016; 54:2609–2613.
78. Lau AF, Wang H, Weingarten RA, et al. A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of
carbapenem-resistant Enterobacteriaceae. J. Clin. Microbiol, 2014;52, 2804–2812.
79. Chatterjee SS, Chen L, Joo HS, Cheung GY, Kreiswirth BN, Otto M. Distribution and regulation of the mobile genetic element-encoded phenol-soluble modulin PSM-mec in methicillin-re-
sistant Staphylococcus aureus. PLoS ONE, 2011: e28781.
80. Rhoads DD, Wang H, Karichu J, Richter SS. The presence of a single MALDI-TOF mass spectral peak predicts methicillin resistance in staphylococci. Diagn. Microbiol. Infect. Dis, 2016; 86,
257–261.
81. Cabrolier N, Sauget M, Bertrand X, Hocquet D. Matrix-assisted laser desorption ionization-time of flight mass spectrometry identifies Pseudomonas aeruginosa high-risk clones. J. Clin.
Microbiol, 2015; 53:1395–1398.
82. Mulet X, Garcia R, Gaya M, Oliver A. O-antigen serotyping and MALDI-TOF, potentially useful tools for optimizing semi-empiric antipseudomonal treatments through the early detection
of high-risk clones. Eur. J. Clin. Microbiol. Infect. Dis, 2019; 38:541–544.
83. Jung JS, Popp C, Sparbier K, Lange C, Kostrzewa M, Schubert S. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid detection of beta-lactam
resistance in Enterobacteriaceae derived from blood cultures. J. Clin. Microbiol, 2014; 52:924–930.
84. Sauget M, Bertrand X, Hocquet D. Rapid antibiotic susceptibility testing on blood cultures using MALDI-TOF MS. PLoS ONE, 2018; 13: e0205603.
85. Sparbier K, Lange C, Jung J, Wieser A, Schubert S, Kostrzewa M. MALDI biotyper-based rapid resistance detection by stable-isotope labeling. J. Clin. Microbiol, 2013; 51:3741–3748.
86. Jung JS, Eberl T, Sparbier K, et al. Rapid detection of antibiotic resistance based on mass spectrometry and stable isotopes. Eur. J. Clin. Microbiol. Infect. Dis, 2014;33: 949–955.
87. Idelevich EA., Sparbier K, Kostrzewa M, Becker K. Rapid detection of antibiotic resistance by MALDI-TOF mass spectrometry using a novel direct-on-target microdroplet growth assay. Clin.
Microbiol. Infect, 2018; 24: 738–743.
88. Correa-Martinez C L, Idelevich EA, Sparbier K, Kostrzewa M, Becker K. Rapid detection of extended-spectrum beta-lactamases (ESBL) and AmpC beta-lactamases in Enterobacterales:
development of a screening panel using the MALDI-TOF MS-based direct-on-target microdroplet growth assay. Front. Microbiol, 2019; 10:13
89. Altınkanat Gelmez G, Can B, Hasdemir U, Söyletir G. VITEK-MS Sistemi ile Karbapenemaz Üretiminin Hızlı Tespiti. ANKEM Derg 2019;33(1):24-30.
90. Uprety P, Kirn TJ. Molecular Detection of Antibacterial Drug Resistance In: Carroll KC, Pfaller MA Manual of Clinical Microbiology, 12th Edition, 2023, ASM Press, Washington, DC
91. Anjum MF, Zankari E, Hasman H. Molecular Methods for Detection of Antimicrobial Resistance. Microbiol Spectr, 2017;5(6).
92. Tibbetts RJ. Antibiotic Susceptibility Testing Paradigms: Current Status and Future Directions. Clin Lab Sci, 2018;31(2):81-87
93. Banerjee R, Patel R. Molecular diagnostics for genotypic detection of antibiotic resistance: current landscape and future directions. JAC Antimicrob Resist. 2023,17;5(1):dlad018.
94. http://www.eurl-ar.eu/data/images/faq/primerliste%20til%20web_07.11.2013.pdf
95. http://lcpdb.ddlemb.com/args/
96. De Angelis G, Grossi A, Menchinelli G, Boccia S, Sanguinetti M, Posteraro B. Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from
positive blood cultures: a systematic review and meta-analysis. Clin Microbiol Infect, 2020;26:271-280.
97. Lu N, Hu Y, Zhu L et al. DNA microarray analysis reveals that antibiotic resistance-gene diversity in human gut microbiota is age related. Sci Rep. 2014, 4:4302
98. Sanger F, Nicklen S, Coulson R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci, 1977;74(12):5463-67.
99. Yamin D, Uskoković V, Wakil AM, et al. Current and future technologies for the detection of antibiotic-resistant bacteria. Diagnostics, 2023;13:3246.
100. RS Hendriksen, V Bortolaia, H Tate, GH Tyson, FM Aarestrup, PF McDermott. Using genomics to track global antimicrobial resistance. Front. Public Health, 2019; 7:242.
101. K Faksri, O Kaewprasert, RTH Ong, et al. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XD-
R-TB in Thailand. Int J Antimicrob Agents, 2019; 54:109–116.
102. Vasala A, Hytönen VP, Laitinen OH. Modern tools for rapid diagnostics of antimicrobial resistance. Front Cell Infect Microbiol, 2020 ;10:308.
103. March-Rosselló GA. Rapid methods for detection of bacterial resistance to antibiotics. Enferm Infecc Microbiol Clin, 2017;35(3):182-188.
104. Zhang K, Qin S, Wu S, Liang Y, Li J. Microfluidic systems for rapid antibiotic susceptibility tests (ASTs) at the single cell level. Chem Sci, 2020; 11: 6352.
105. Kasas, S, Malovichko, A, Villalba MI, Vela ME, Yantorno O. Willaert, R.G. Nanomotion Detection-Based Rapid Antibiotic Susceptibility Testing. Antibiotics, 2021; 10:287.
106. Kandavalli V, Karempudi P, Larsson J & Elf J. Rapid antibiotic susceptibility testing and species identification for mixed samples. Nature Communications, 2022;13:6215.
107. ZKhan ZA, Siddiqui MF and Park S. Current and Emerging Methods of Antibiotic Susceptibility Testing. Diagnostics, 2019;9:49.
108. Langford B, Daneman N, Diong C, et al. Antibiotic susceptibility reporting and association with antibiotic prescribing: a cohort study. Clin Microbiol Infect, 2021;27:568e75.
109. Langford BJ, Seah J, Chan A et al. Antimicrobial Stewardship in the Microbiology Laboratory: Impact of Selective Susceptibility Reporting on Ciprofloxacin Utilization and Susceptibility of
Gram-Negative Isolates to Ciprofloxacin in a Hospital Setting. J Clin Microbiol, 2016; 54:2343-7).
110. Langford BJ, Leung E, Haj R, McIntyre M, Taggart LR, Brown KA, et al. Nudging in microbiology laboratory evaluation (NIMBLE): a scoping review. Infect Contr Hosp Epidemiol,
2019;40:1400e6.
111. Tebano G, Mouelhi Y, Zanichelli V, et al. Selective reporting of antibiotic susceptibility testing results: a promising antibiotic stewardship tool. Expert Rev Anti Infect Ther, 2020;18:251e62.
112. Pulcini C, Tebano G, Mutters NT, et al. Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey. International Journal of Antimic-
robial Agents, 2017 ;49(2):162-166
113. https://www.cdc.gov/antibiotic-use/pdfs/Selective-Reporting-508.pdf
114. https://www.rcpa.edu.au/getattachment/fdc6ceac-5993-4262-8284-f3aada95255e/Selective-Reporting-of-Antimicrobials.aspx
115. https://www.tmc-online.org/userfiles/file/TMC-ADTS%20K%C4%B1s%C4%B1tl%C4%B1%20Bildirim%20Tablolar%C4%B1%202022%20(pdf%20dosyas%C4%B1-).pd